NDAINJECTIONINJECTABLE
Approved
Jan 1947
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 19h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Tubocurarine chloride is a non-depolarizing neuromuscular blocking agent administered by injection for use during anesthesia and surgery. It works by competitively blocking acetylcholine at the neuromuscular junction, causing muscle paralysis. This historic agent has been a foundational product in anesthetic practice since its approval in 1947.
LOE Approaching
As a mature, near-LOE product with low ongoing commercial activity (0 linked jobs), this represents a legacy franchise with minimal team expansion opportunities.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on tubocurarine chloride offers limited career advancement given its LOE-approaching status and zero linked job openings. This role is suited for professionals managing legacy franchises or seeking stability in a maintenance-focused environment rather than growth-oriented careers.
Product ManagerCommercial Operations
Worked on TUBOCURARINE CHLORIDE at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.